Flinton Capital Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$102K Buy
5,656
+112
+2% +$1.85K ﹤0.01% 766
2019
Q2
$87K Buy
5,544
+952
+21% +$18.7K ﹤0.01% 795
2019
Q1
$105K Hold
4,592
﹤0.01% 764
2018
Q4
$107K Hold
4,592
﹤0.01% 746
2018
Q3
$152K Buy
4,592
+1,792
+64% +$67K ﹤0.01% 742
2018
Q2
$123K Hold
2,800
﹤0.01% 734
2018
Q1
$117K Hold
2,800
﹤0.01% 734
2017
Q4
$128K Buy
2,800
+364
+15% +$14.3K ﹤0.01% 729
2017
Q3
$81K Buy
2,436
+112
+5% +$4.56K ﹤0.01% 763
2017
Q2
$94K Buy
2,324
+112
+5% +$3.47K ﹤0.01% 718
2017
Q1
$44K Buy
2,212
+224
+11% +$4.74K ﹤0.01% 762
2016
Q4
$46K Buy
+1,988
New +$42.6K ﹤0.01% 730

Other funds holding PETS

Flinton Capital Management's PETS Position: Q3 2019 in Review

Flinton Capital Management increased its PetMed Express (PETS) stake by 2% in Q3 2019, buying an estimated $1.85K and bringing the position to 5,656 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

Flinton Capital Management first reported a position in PETS in Q4 2016 and has held it in 12 quarters since. The position peaked at $152K in Q3 2018. 170 funds tracked by Wall St. Rank hold PETS as of Q3 2019.

  • Flinton Capital Management held 5,656 shares of PetMed Express worth $102K as of Q3 2019.
  • Flinton Capital Management bought 112 PetMed Express shares in Q3 2019, an estimated $1.85K.
  • PetMed Express made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #766 holding.
  • Flinton Capital Management first reported a position in PetMed Express in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's PetMed Express position peaked at $152K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held PetMed Express as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.